Get the information you need to find better investment opportunities and minimize risk in 2023 with our #JPM2023 J.P.Morgan coverage. Sign up today for our critical coverage including daily updates from Citeline experts straight into your inbox.
Register for Updates
What to Expect
Scrip Commercial
E-book
Keep up with the fast-moving biopharmaceutical markets and be informed about the developments that matter ahead of the competition.
JP Morgan Outlook 2023
Extract
Access the most powerful, comprehensive view of the year to come, including the predicted drug, device, and diagnostic catalysts expected for the quarter ahead.
JP Morgan Preview
Report
Before the conference kicks off, we’ve selected our picks of who to watch throughout the week.
Seize market opportunities and learn about major marketplace trends.
Daily Update
One
Download the key takeaways from Day 1 of the conference.
Daily Update
Two
Download the key takeaways from Day 2 of the conference.
Daily Update
Three
Download the key takeaways from Day 3 of the conference.
Daily Update
Four
Download the key takeaways from Day 4 of the conference.
JP Morgan Post Conference Report
Get our full conference report to receive all of the essential information covered from the 2023 conference.
Our Analysts
Mandy Jackson
Managing Editor,
US Commercial News
Mandy is Managing Editor, US Commercial News. Mandy reports on daily biopharma developments, writes feature stories, produces the Finance Watch column and oversees Emerging Company Profiles. She covers finance, start-ups, dealmaking, clinic
Jess Merrill
Senior Editor
Jessica is a senior editor at Citeline, contributing most frequently to daily pharmaceutical coverage in Scrip and Pink Sheet. With a lengthy career covering the pharmaceutical sector, she specializes primarily in business and commercial news, launch strategy, M&A and market access issues. She is based in New York City.